Busch Susan H, Epstein Andrew J, Harhay Michael O, Fiellin David A, Un Hyong, Leader Deane, Barry Colleen L
Yale School of Public Health, 60 College St, New Haven CT 06520-8034.
Am J Manag Care. 2014;20(1):76-82.
In 2008, the US Congress enacted the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) requiring insurers to equalize private insurance coverage for mental health and substance use disorder services with coverage for general medical services.
To examine the effects of MHPAEA on substance use disorder treatment.
We used a difference-in-differences design to compare changes in outcomes among plan enrollees in the years before and after implementation of federal parity (2009-2010) with changes in outcomes among a comparison group of enrollees previously covered by state substance use disorder parity laws.
Insurance claims data from Aetna Inc health plans in 10 states with state parity laws were used to compare outcomes for plan enrollees in fully insured and self-insured health plans (N = 298,339).
In the first year of implementation, we found that federal parity did not lead to changes in the proportion of enrollees using substance use disorder treatment. We did find a modest increase in spending on substance use disorder treatment per enrollee ($9.99, 95% confidence interval, 2.54-18.21), but no significant change in identification, treatment initiation, or treatment engagement.
Inclusion of substance use disorder services in the federal parity law did not result in substantial increases in health plan spending. It will be critical to study results for year 2 after regulations affecting the management of care (eg, utilization review, network access) take effect.
2008年,美国国会颁布了《保罗·韦尔斯通和皮特·多梅尼基精神卫生平等与成瘾公平法案》(MHPAEA),要求保险公司使私人保险对精神卫生和物质使用障碍服务的覆盖范围与对一般医疗服务的覆盖范围相等。
研究MHPAEA对物质使用障碍治疗的影响。
我们采用了差异中的差异设计,以比较联邦平等法案实施前后(2009 - 2010年)计划参保者的结果变化与先前受州物质使用障碍平等法覆盖的参保者对照组的结果变化。
使用来自安泰保险公司在10个有州平等法的州的健康计划的保险理赔数据,比较完全保险和自我保险健康计划中计划参保者的结果(N = 298,339)。
在实施的第一年,我们发现联邦平等法案并未导致使用物质使用障碍治疗的参保者比例发生变化。我们确实发现每位参保者在物质使用障碍治疗上的支出有适度增加(9.99美元,95%置信区间,2.54 - 18.21),但在识别、开始治疗或参与治疗方面没有显著变化。
将物质使用障碍服务纳入联邦平等法案并未导致健康计划支出大幅增加。研究影响护理管理(如利用审查、网络接入)的法规生效后第二年的结果至关重要。